11 results
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm
physical and cognitive disability. There are many different symptoms of MS, including fatigue, numbness, walking and balance problems, bladder
8-K
GSTC
GlobeStar Therapeutics Corp
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
cells. The disease can manifest with a wide range of neurological symptoms and can progress to total physical and cognitive disability. There are many
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
22 Jun 23
Globestar Therapeutics Enters into Mou with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
5:18pm
disease and 60 healthy volunteers, the average Expanded Disability Status Scale (EDSS) score for subjects with MS dropped by at least 1.3 points for pre
8-K
EX-99
6brkm hw37z
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
8-K
3xdxq4w
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
8-K
tt4nd bo9mqnqdfjor4
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm
PRE 14A
kpqg8arup4h
22 Jan 15
Preliminary proxy
12:00am
8-K
EX-99
el7h5j
13 Nov 23
Other Events
12:32pm
- Prev
- 1
- Next